Page last updated: 2024-09-02
zacopride and fura-2
zacopride has been researched along with fura-2 in 1 studies
Compound Research Comparison
| Studies (zacopride) | Trials (zacopride) | Recent Studies (post-2010) (zacopride) | Studies (fura-2) | Trials (fura-2) | Recent Studies (post-2010) (fura-2) |
|---|---|---|---|---|---|
| 180 | 4 | 16 | 4,362 | 12 | 291 |
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Nishida, A; Shimizu, M; Yamawaki, S; Zensho, H | 1 |
Other Studies
1 other study(ies) available for zacopride and fura-2
| Article | Year |
|---|---|
Chronic amitriptyline exposure reduces 5-HT3 receptor-mediated cyclic GMP formation in NG 108-15 cells.
Topics: Amitriptyline; Antidepressive Agents, Tricyclic; Benzamides; Bradykinin; Brain Neoplasms; Bridged Bicyclo Compounds, Heterocyclic; Calcium; Cyclic GMP; Fluorescent Dyes; Fura-2; Glioma; Hybrid Cells; Indoles; Kinetics; Neuroblastoma; Receptors, Serotonin; Serotonin Antagonists; Tropisetron; Tumor Cells, Cultured | 1996 |